Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
SCH56592 treatment of murine invasive aspergillosis.
Graybill JR, Bocanegra R, Najvar LK, Luther MF, Loebenberg D. Graybill JR, et al. Among authors: bocanegra r. J Antimicrob Chemother. 1998 Oct;42(4):539-42. doi: 10.1093/jac/42.4.539. J Antimicrob Chemother. 1998. PMID: 9818757
Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.
Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Patterson TF, Thornton CR. Wiederhold NP, et al. Among authors: bocanegra r. J Clin Microbiol. 2013 Feb;51(2):459-65. doi: 10.1128/JCM.02142-12. Epub 2012 Nov 21. J Clin Microbiol. 2013. PMID: 23175252 Free PMC article.
Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.
Wiederhold NP, Thornton CR, Najvar LK, Kirkpatrick WR, Bocanegra R, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. Clin Vaccine Immunol. 2009 Dec;16(12):1844-6. doi: 10.1128/CVI.00268-09. Epub 2009 Sep 30. Clin Vaccine Immunol. 2009. PMID: 19793899 Free PMC article.
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA, Wiederhold NP, McConville JT, Peters JI, Najvar LK, Graybill JR, Coalson JJ, Talbert RL, Burgess DS, Bocanegra R, Johnston KP, Williams RO 3rd. Alvarez CA, et al. Among authors: bocanegra r. J Infect. 2007 Jul;55(1):68-74. doi: 10.1016/j.jinf.2007.01.014. Epub 2007 Mar 13. J Infect. 2007. PMID: 17360039
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, Molina D, Olivo M, Graybill JR, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. Antimicrob Agents Chemother. 2008 Mar;52(3):1176-8. doi: 10.1128/AAC.01425-07. Epub 2007 Dec 26. Antimicrob Agents Chemother. 2008. PMID: 18160526 Free PMC article.
Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Kadosh D, Najvar LK, Bocanegra R, Olivo M, Kirkpatrick WR, Wiederhold NP, Patterson TF. Kadosh D, et al. Among authors: bocanegra r. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6703-6708. doi: 10.1128/AAC.01144-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27572393 Free PMC article.
Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.
Wiederhold NP, Kovanda L, Najvar LK, Bocanegra R, Olivo M, Kirkpatrick WR, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5600-3. doi: 10.1128/AAC.00229-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27324761 Free PMC article.
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.
Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, Fukuda Y, Mitsuyama J, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. J Antimicrob Chemother. 2016 Mar;71(3):692-5. doi: 10.1093/jac/dkv398. Epub 2015 Nov 29. J Antimicrob Chemother. 2016. PMID: 26620102 Free PMC article.
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.
Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, Kirkpatrick WR, Fukuda Y, Mitsuyama J, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. Antimicrob Agents Chemother. 2015 Feb;59(2):1341-3. doi: 10.1128/AAC.04228-14. Epub 2014 Dec 1. Antimicrob Agents Chemother. 2015. PMID: 25451054 Free PMC article.
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Wiederhold NP, Najvar LK, Fothergill AW, McCarthy DI, Bocanegra R, Olivo M, Kirkpatrick WR, Everson MP, Duncanson FP, Patterson TF. Wiederhold NP, et al. Among authors: bocanegra r. Antimicrob Agents Chemother. 2015 Jan;59(1):690-2. doi: 10.1128/AAC.03944-14. Epub 2014 Oct 20. Antimicrob Agents Chemother. 2015. PMID: 25331706 Free PMC article.
75 results
Jump to page
Feedback